Clover Health Investments (NASDAQ: CLOV) reported Q2 EPS of $0.00, $0.05 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $356.3 million versus the consensus estimate of $338.76 million.

GUIDANCE:

Clover Health Investments sees FY2024 revenue of $1.35-1.37 billion, versus the consensus of $1.34 billion.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.